Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fractyl Health (GUTS) Operating Expenses (2023 - 2025)

Fractyl Health (GUTS) has disclosed Operating Expenses for 3 consecutive years, with $22.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Expenses fell 4.65% year-over-year to $22.7 million, compared with a TTM value of $98.7 million through Sep 2025, up 21.39%, and an annual FY2024 reading of $93.6 million, up 83.91% over the prior year.
  • Operating Expenses was $22.7 million for Q3 2025 at Fractyl Health, down from $26.1 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $26.1 million in Q2 2025 and bottomed at $11.9 million in Q2 2023.
  • Average Operating Expenses over 3 years is $19.8 million, with a median of $22.7 million recorded in 2025.
  • The sharpest move saw Operating Expenses skyrocketed 94.16% in 2024, then dropped 4.65% in 2025.
  • Year by year, Operating Expenses stood at $13.0 million in 2023, then surged by 94.16% to $25.2 million in 2024, then decreased by 9.99% to $22.7 million in 2025.
  • Business Quant data shows Operating Expenses for GUTS at $22.7 million in Q3 2025, $26.1 million in Q2 2025, and $24.8 million in Q1 2025.